Serum total homocysteine levels and the prevalence of folic acid deficiency and C677T mutation at the MTHFR gene in an indigenous population of Amazonia: The relationship of homocysteine with other cardiovascular risk factors

Ethnicity and Disease

Volumn 14, Issue 1, 2004, Pages 49-56

  Tavares, Edelweiss F ^a   Vieira Filho, João P B ^a   Andriolo, Adagmar ^a   Perez, Ana B A ^a   Vergani, Naja ^a   Sañudo, Adriana ^a   Gimeno, Suely G A ^a   Franco, Laércio J ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Brazilian Indians; C677T mutation; Cardiovascular risk factors; Folic acid; Homocysteine; MTHFR; Vitamin B 12

Indexed keywords

ALCOHOL; CREATININE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); TRIACYLGLYCEROL;

ADULT; AGE; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; BRAZIL; CARDIOVASCULAR RISK; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYANOCOBALAMIN DEFICIENCY; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; FOLIC ACID DEFICIENCY; GENDER; GENE MUTATION; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; INDIAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; RISK FACTOR; SMOKING; STATISTICAL MODEL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BRAZIL; CARDIOVASCULAR DISEASES; FEMALE; FOLIC ACID DEFICIENCY; HEALTH STATUS INDICATORS; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; INDIANS, SOUTH AMERICAN; LINEAR MODELS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; RISK FACTORS; SEX FACTORS; SMOKING; VITAMIN B 12;

EID: 1342288111     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995;274(13): 1049-1057.
2. Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med. 1999; 131:363-375.
3. Kang S, Zhou J, Wong PWK, Kowalisyn J, Strokosch G. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet. 1988; 43:414-421.
4. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111-113.
5. Rozen R. Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb Haemost. 1997;78(1):523-526.
6. Botto LD, Yang Q. 5,10-methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE Review. Am J Epidemiol. 2000;151(9):862-877.
7. Selbub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993;270(22): 2693-2698.
8. Nygard O, Vollset SE, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA. 1995;274(19):1526-1533.
9. Jacques PF, Rosenberg IH, Rogers G, et al. Serum total homocysteine concentrations in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr. 1999;69: 482-489.
10. Olszewski AJ, Szostak WB, Bialkowska M, Rudnicki S, McCully KS. Reduction of plasma lipid and homocysteine levels by pyridoxine, folate, cobalamin, choline, riboflavin, and troxerutin in atherosclerosis. Atherosclerosis. 1989;75:1-6.
11. Cravo ML, Glória LM, Selhub J, et al. Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitamin B-12, and vitamin B-6 status. Am J Clin Nutr. 1996;63: 220-224.
12. Bostom AG, Lathrop L. Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int. 1997;52:10-20.
13. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomized trials. BMJ. 1998;316:894-898.
14. Howard BV, Lee ET Cowan LD, et al. Rising tide of cardiovascular disease in American Indians. The Strong Heart Study. Circulation. 1999;99:2389-2395.
15. Ricardo CA, Gavião. In: Ricardo CA, ed. Povos Indígenas no Brasil Vol. 8: Sudeste do Pará (Tocantins). São Paulo: CEDI; 1985:53-99.
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502.
17. Siedel J, Hägele EO, Ziegenhorn J, Wahlefeld AW, Reagent for the enzymatic determination of serum cholesterol with improved lipolytic efficiency. Clin Chem. 1983;29:1075-1080.
18. Siedel J, Schmuck R, Staepels J, Town MH. Long term stable liquid ready-to-use monoreagent for the enzymatic assay of serum or plasma triglycerides (GPO-PAP method). AACC Meeting. Abstract 34. Clin Chem. 1993;39:1127.
19. Sugiuchi H, Uji Y, Okabe H, et al. Direct measurement of High Density Lipoprotein Cholesterol in serum with polyethylene glycol-modified enzymes and sulfated α-cyclodextrin. Clin Chem. 1995;41(5):717-723.
20. Ubbink JB, Vermaak WJH, Bissbort S. Rapid high-performance liquid chromatographic assay for total homocystcine levels in human serum. J Chromatogr. 1991;565:441-446.
21. Chen IW, Sperling MI, Heminger LA. Vitamin B12. In: Kaplan LA, Pesce AJ, eds. Methods in Clinical Chemistry. St. Louis, Mo: CV Mosby; 1987:569-573.
22. McNeely MDD. Folic acid. In: Kaplan LA, Pesce AJ, eds. Methods in Clinical Chemistry. St. Louis, Mo: CV Mosby; 1987:539-542.
23. Bartels H, Böhmer M, Heierli C. Serum Kreatininbestimmung ohne enteiweissen. Clin Chim Acta. 1972;37:193-197.
24. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
25. Goyette P, Frosst P, Rosenblatt DS, Rozen R. Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am J Hum Genet. 1995;56:1052-1059.
26. Robinson K, Mayer EL, Miller DP, et al. Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. Circulation. 1995;92:2825-2830.
27. National Institutes of Health. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, Md: National Institutes of Health; 1997. NIH Publication No. 98-4080.
28. Sociedade Brasileira de Cardiologia. Consenso Brasileiro, sobre Dislipidemias - detecção-avaliação-tratamento. Arq Bras Cardiol. 1996;67: 110-128.
29. Berquó E, Gotlieb SLD, Souza JMP. Bioestatística. São Paulo: EPU; 1986.
30. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homecysteine in plasma or serum: methods and clinical applications. Clin Chem. 1993;39(9): 1764-1779.
31. Duchnan NPB, Guo XG, Crooks R, Xie L, Silberberg JS. Assay of plasma homocysteine: light sensitivity of the fluorescent 7-benzo-2-oxa-1, 3-diazole-4-sulfonic acid derivative, and use of appropriate standards. Clin Chem. 1996;42:2028.
32. Shaw JTE, McWhinney B, Tate JR, et al. Plasma homocysteine levels in indigenous Australians. Med J Aust. 1999;170:19-22.
33. Arnesen E, Refsum H, Bonaa KH, Ueland PM, Forde OH, Nordrehaug JE. Serum total homocysteine and coronary heart disease. Int J Epidemiol. 1995;24(4):704-709.
34. Welty TK, Lee ET, Yeh J, et al. Cardiovascular disease risk factors among American Indians. The Strong Heart Study. Am J Epidemiol 1995;142:269-287.
35. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 1997;277:1775-1781.
36. Diez-Ewald M, Torres-Guerra E, Layrisse M, Leets I, Vizcaíno G, Arteaga-Vizcaíno M. Prevalence of anemia, iron, folic acid, and vitamin B12 deficiency in two Bari Indian communities from Western Venezuela. Invest Clin. 1997;38(4):191-201.
37. Arruda VR, Siqueira LH, Gonçalves MS, et al. Prevalence of the mutation C677T in the methylene tetrahydrofolate reductase gene among distinct ethnic groups in Brazil. Am J Med Genet. 1998;78:332-335.
38. Franco RF, Araújo AG, Guerreiro, JF, Elion J, Zago MA. Analysis of the 677 C→T mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups. Thromb Haemost. 1998;79:119-121.
39. Schneider JA, Rees DC, Liu Y, Clegg JB. Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. Am J Hum Genet. 1998;62:1258-1260.
40. Hanson RL, Narayan KM, McCance DR, et al. Rate of weight gain, weight fluctuation, and incidence of NIDDM. Diabetes. 1995; 44:261-266.
41. Coitinho DC, Leão MM, Recine E, Sichieri R. Ministério da Saúde. Instituto Nacional de Alimentação e Nutrição-INAN. Condições Nutricionais da População Brasileira: Adultos e Idosos. Brasília: INAN; 1991.
42. Mancilha-Carvalho JJ, Baruzzi RG, Howard PF, et al. Blood pressure in four remote populations in the INTERSALT study. Hypertension. 1989;14:238-246.
43. Fleming-Moran M, Santos RV, Coimbra CEA Jr. Blood pressure levels of the Suruí and Zoró Indians of the Brazilian Amazon: group- and sex-specific effects resulting from body composition, health status, and age. Hum Biol. 1991;63(6):835-861.
44. Pavan L, Casiglia E, Braga LMC, et al. Effects of a traditional lifestyle on the cardiovascular risk profile: the Amondava population of the Brazilian Amazon. Comparison with matched African, Italian, and Polish populations. J Hypertens. 1999;17:749-756.
45. Howard BV, Lee ET, Yeh JL, et al. Hypertension in adult American Indians. The Strong Heart Study. Hypertension. 1996;28:256-264.
46. Nascimento JRL, Miranda RA, Xavier FB, Menezes RC. Hipertensão arterial em índios adultos da tribo Tembé, nordeste do estado do Pará. Rev Paraense Med. 1998;12(3):45-48.
47. Baruzzi R, Franco L. Ameridians of Brazil. In: Trowell HC, Burkitt DP, eds. Western Diseases: Their Emergence and Prevention. London: Edward Arnold Ltd; 1981:138-153.
48. Mancilha-Carvalho JJ, Crews DE. Lipid profiles of Yanomamo Indians of Brazil. Prev Med. 1990;19:66-75.